» Articles » PMID: 37908567

Maternally Inherited Diabetes and Deafness (MIDD) - Atypical Clinical Diabetes Features Leading to the Diagnosis

Overview
Journal JCEM Case Rep
Specialty Endocrinology
Date 2023 Nov 1
PMID 37908567
Authors
Affiliations
Soon will be listed here.
Abstract

Maternally inherited diabetes and deafness (MIDD) syndrome refers to a rarely diagnosed disorder caused by pathogenic variants in mtDNA. It was first identified in 1992 and, to date, is considered underdiagnosed because of misclassification to type 1 or type 2 diabetes mellitus. MIDD reflects a multisystem metabolic syndrome commonly resulting in insulin-requiring diabetes and sensorineural deafness but can also lead to a broad range of other manifestations. The spectrum of pathology differs among individuals, likely because of varied degrees of heteroplasmy associated with mtDNA. Heteroplasmy also creates diagnostic difficulties, with a high index of suspicion required to diagnose MIDD in some cases. Here, we review a patient with MIDD who presented with an atypical clinical diabetes picture, additionally documenting his pedigree. To our knowledge, this is the first Cypriot reported with MIDD.

Citing Articles

Mitochondrial DNA variants in the pathogenesis and metabolic alterations of diabetes mellitus.

K S P, Jyothi M, Prashant A Mol Genet Metab Rep. 2025; 42():101183.

PMID: 39835172 PMC: 11743804. DOI: 10.1016/j.ymgmr.2024.101183.


Mitochondrial diabetes plus phenotypes due to the m.3243A > G variant require correlation with heteroplasmy rates.

Finsterer J Clin Case Rep. 2024; 12(5):e8862.

PMID: 38721557 PMC: 11077234. DOI: 10.1002/ccr3.8862.

References
1.
Stewart J, Chinnery P . The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat Rev Genet. 2015; 16(9):530-42. DOI: 10.1038/nrg3966. View

2.
Sato M, Sato K . Maternal inheritance of mitochondrial DNA by diverse mechanisms to eliminate paternal mitochondrial DNA. Biochim Biophys Acta. 2013; 1833(8):1979-84. DOI: 10.1016/j.bbamcr.2013.03.010. View

3.
Guery B, Choukroun G, Noel L, Clavel P, Rotig A, Lebon S . The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol. 2003; 14(8):2099-108. DOI: 10.1097/01.asn.0000080180.51098.02. View

4.
Fromont I, Nicoli F, Valero R, Felician O, Lebail B, Lefur Y . Brain anomalies in maternally inherited diabetes and deafness syndrome. J Neurol. 2009; 256(10):1696-704. DOI: 10.1007/s00415-009-5185-4. View

5.
Yeung R, Al Jundi M, Gubbi S, Bompu M, Sirrs S, Tarnopolsky M . Management of mitochondrial diabetes in the era of novel therapies. J Diabetes Complications. 2020; 35(1):107584. PMC: 7554068. DOI: 10.1016/j.jdiacomp.2020.107584. View